Private Advisor Group’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
Other funds holding PBE
Private Advisor Group's PBE Position: Q3 2026 in Review
Private Advisor Group opened a new position in Invesco Biotechnology & Genome ETF (PBE) in Q3 2026: 8,239 shares worth $802K. The stake represents ﹤0.01% of the portfolio and ranks #1825 among its holdings. This is a return to the name: Private Advisor Group previously reported a position in PBE as recently as Q1 2024.
Private Advisor Group first reported a position in PBE in Q3 2014 and has held it in 8 quarters since. 122 funds tracked by Wall St. Rank hold PBE as of Q3 2026.
- Private Advisor Group held 8,239 shares of Invesco Biotechnology & Genome ETF worth $802K as of Q3 2026.
- Invesco Biotechnology & Genome ETF was a new Private Advisor Group position in Q3 2026.
- Invesco Biotechnology & Genome ETF made up ﹤0.01% of Private Advisor Group's portfolio in Q3 2026, its #1825 holding.
- Private Advisor Group first reported a position in Invesco Biotechnology & Genome ETF in Q3 2014 and has held it in 8 quarters since.
- 122 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q3 2026.
Based on Private Advisor Group's 13F filing for Q3 2026, filed 10 Nov 2026.